Nath Bio-Genes reported a 20.75% increase in net sales at Rs. 51.97 crore for March 2025 compared to Rs. 43.04 crore in March 2024. However, net profit dropped 43.45% to Rs. 1.48 crore, and EPS declined to Rs. 1.14 from Rs. 1.87. The company's shares closed at 157.31 on NSE, yielding -16.30% returns over six months and -23.75% over 12 months.
Read more at MoneycontrolAd
Ad